Systematic review / meta-analysis / 2020
Ginkgo biloba preparation was associated with improved cognitive function and global clinical assessment in Alzheimer disease patients.
A systematic review and meta-analysis of seven studies (N = 939) evaluated the efficacy and safety of Ginkgo biloba preparation for treating Alzheimer disease. Compared with placebo, Ginkgo biloba demonstrated benefits in cognitive function (risk ratio = 1.98, 95% confidence interval = 1.52-2.59, Z = 5.12, P < 0.001) and global clinical assessment via Clinical Global Impression Change (odds ratio = 3.119, 95% confidence interval = 2.206-4.410, Z = 6.44, P < 0.001). Adverse events were reported as mild.
- Study type
- Systematic review and meta-analysis
- Who was studied
- 939 Alzheimer disease patients across 7 studies
- What was measured
- Cognitive function, global clinical assessment, and adverse events
THE PAPER
Meta-analysis of Ginkgo biloba Preparation for the Treatment of Alzheimer's Disease.
Liao Z, Cheng L, Li X, Zhang M, Wang S, Huo R. Clin Neuropharmacol, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.